Spinal Simplicity closed a financing round with an investment from Nueterra Capital. Funds will support U.S. launch of the Minuteman fusion device to treat low back pain.
Minuteman received CE Mark approval in 2011; in 2015, Spinal Simplicity received FDA 510(k) clearance for the HA Minuteman G3 MIS Fusion Plate and Minuteman Percutaneous Interlaminar Fusion system. The device, available in five sizes, is pre-packaged sterile and will be offered with hydroxyapatite coating to facilitate fusion.
Further, the investment provides access to the global NueHealth system of healthcare providers.
Spinal Simplicity closed a financing round with an investment from Nueterra Capital. Funds will support U.S. launch of the Minuteman fusion device to treat low back pain.
Minuteman received CE Mark approval in 2011; in 2015, Spinal Simplicity received FDA 510(k) clearance for the HA Minuteman G3 MIS Fusion Plate and Minuteman Percutaneous...
Spinal Simplicity closed a financing round with an investment from Nueterra Capital. Funds will support U.S. launch of the Minuteman fusion device to treat low back pain.
Minuteman received CE Mark approval in 2011; in 2015, Spinal Simplicity received FDA 510(k) clearance for the HA Minuteman G3 MIS Fusion Plate and Minuteman Percutaneous Interlaminar Fusion system. The device, available in five sizes, is pre-packaged sterile and will be offered with hydroxyapatite coating to facilitate fusion.
Further, the investment provides access to the global NueHealth system of healthcare providers.
Copy to clipboard 
